Summary of Non-Qualified Stock Options (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	840,852		840,852		1,248,115
Granted (in shares)			0
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised			(406,625)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures			(638)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	799,354		799,354
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 59.71		$ 59.71		$ 62.02
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			0
Weighted Average Exercise Price, Exercises in Period (in dollars per share)			66.80
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)			72.15
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 58.81		$ 58.81
Weighted Average Remaining Contractual Term, Outstanding (in years)			5 years 6 months
Aggregate Intrinsic Value, Outstanding	$ 100.4		$ 100.4
Weighted Average Remaining Contractual Term, Exercisable (in years)			5 years 4 months 24 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 96.1		$ 96.1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value			$ 37.9
Share-based Payment Arrangement, Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	163,204		163,204		87,347
Granted (in shares)	1,954	0	77,136	89,550
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised			(1,279)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	27,782		27,782
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 144.44		$ 144.44		$ 121.55
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			169.99
Weighted Average Exercise Price, Exercises in Period (in dollars per share)			122.09
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)			0
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 121.89		$ 121.89
Weighted Average Remaining Contractual Term, Outstanding (in years)			9 years 1 month 6 days
Aggregate Intrinsic Value, Outstanding	$ 5.7		$ 5.7
Weighted Average Remaining Contractual Term, Exercisable (in years)			8 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 1.6		$ 1.6